PDCD1 and diabetes mellitus: In addition, systematic search of PubMed, CNKI, WANFANG, VIP (the latter three, Chinese article databases) using the terms “tislelizumab” or “immune checkpoint inhibitor” or “PD-1 inhibitor” and “diabetes” or “ketoacidosis” were performed.